| tablets | Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (12 Dec 1998) |
|---|---|
| tablets, enteric-coated | Tablets coated with material that delays release of the medication until after they leave the stomach. (12 Dec 1998) |
| met | 1. <oncogene> An oncogene, identified in mouse osteosarcoma. 2. <chemistry> Having less than the highest number of hydroxyl groups; said of acids; as, metaphosphoric acid. Also used adjectively. (04 Mar 1998) |
| met enkephalin | <protein> See enkephalins. (18 Nov 1997) |
| Met-enkephalin heptapeptide dipeptidase | <enzyme> Enzyme from rabbit ear artery forms met-enkephalin from met(5)-enkephalin-arg(6)-phe(7); inhibited by captopril Registry number: EC 3.4.15.- Synonym: met-enkephalin-arg(6)-phe(7) cleavage enzyme, me-ap dipeptidase (26 Jun 1999) |
| RNA, transfer, met | A transfer RNA which is specific for carrying methionine to sites on the ribosomes in preparation for protein elongation. Initiation of protein synthesis uses trna(f)met in prokaryotic cells and trna(I)met in eukaryotic cells. (12 Dec 1998) |
| met repressor operator complex | Repressor protein, 104 residues, product of the metJ gene, which regulates methionine biosynthesis in E. Coli. Dimeric molecules bind to adjacent sites 8 base pairs apart on the DNA, sequence recognition is by interaction between antiparallel strands of protein and the major groove of the B form DNA duplex. (18 Nov 1997) |
| proto-oncogene proteins c-met | <enzyme> A transmembrane tyrosine kinase that is the receptor for hepatocyte growth factor (scatter factor). It consists of an extracellular alpha chain which is disulfide linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and critical sites for the regulation of kinase activity. Registry number: EC 2.7.11.- (12 Dec 1998) |